HeartBeam (BEAT) Other Accumulated Expenses (2020 - 2021)
HeartBeam's (BEAT) quarterly Other Accumulated Expenses came in at $30000.0 in Q3 2021, down 42.31% quarter-over-quarter from $52000.0 in Q4 2020.
Powered by 
Analysis
HeartBeam (BEAT) Other Accumulated Expenses (2020 - 2021) Analysis & Trends
HeartBeam (BEAT) has reported Other Accumulated Expenses for 2 consecutive years, with $30000.0 the latest figure, recorded in Q3 2021.
- On a quarterly basis, Other Accumulated Expenses changed N/A year-over-year to $30000.0 in Q3 2021; TTM through Sep 2021 was $30000.0, a N/A change from a year earlier, with the FY2020 full-year figure at $52000.0, changed N/A from the prior year.
- Other Accumulated Expenses was $30000.0 for Q3 2021 at HeartBeam, down from $52000.0 in the prior quarter.
- Over five years, Other Accumulated Expenses peaked at $52000.0 in Q4 2020 and troughed at $30000.0 in Q3 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn |
| 9 | Resmed | 32.94 Bn | 31.47 Bn | 861.22 Mn |
| 10 | HeartBeam | 24.23 Mn | 24.23 Mn | - |